TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: Accumulating evidence has shown TRPM3 ion channel impairment in various neurological conditions and diseases including neurodegenerative disease, glaucoma, intellectual disability, epilepsy, and recently myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Nguyen et al., 2016; Cabanas et al., 2018; Cabanas et al., 2019; Dyment et al., 2019; Shiels, 2020; Cabanas et al., 2021; Held and Tóth, 2021).